Cargando…
High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
Glioma is the most common primary intracranial malignant tumor in adults. Although there have been many efforts on potential targeted therapy of glioma, the patient’s prognosis remains dismal. Methyltransferase Like 7B (METTL7B) has been found to affect the development of a variety of tumors. In thi...
Autores principales: | Xiong, Yujia, Li, Mingxuan, Bai, Jiwei, Sheng, Yutao, Zhang, Yazhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117938/ https://www.ncbi.nlm.nih.gov/pubmed/33996568 http://dx.doi.org/10.3389/fonc.2021.650534 |
Ejemplares similares
-
PALB2 as a factor to predict the prognosis of patients with skull base chordoma
por: Xiong, Yujia, et al.
Publicado: (2022) -
Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma
por: Shen, Yutao, et al.
Publicado: (2021) -
High systemic inflammation score is associated with adverse survival in skull base chordoma
por: Li, Mingxuan, et al.
Publicado: (2022) -
Endoscopic Endonasal Surgical Strategy for Skull Base Chordomas Based on Tumor Growth Directions: Surgical Outcomes of 167 Patients During 3 Years
por: Bai, Jiwei, et al.
Publicado: (2021) -
Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5
por: Li, Mingxuan, et al.
Publicado: (2021)